The AI examined images of brain cells and was able to identify changes in key areas of the cell that are characteristic of the different known mechanisms that cause Parkinson’s.
On 4 August, the UK government published a plan to address the NHS care backlog in England and give people more choice in who provides their care. We look at what it could mean for people with Parkinson’s.
Parkinson’s UK was chosen as The Access Group's charity of the year in the UK for 2022/2023.
Wednesday 20 September is National Fitness Day: an opportunity for everyone to enjoy being active and try something new.
80-year-old Jon Goodwin was diagnosed with Parkinson’s 9 years ago. Next month, he’s travelling into space.
In May, 2 people with Parkinson’s shared their experiences of pharmacy services in England. Their views have shaped a new parliamentary report.
Created in collaboration with the Parkinson’s community and University College London (UCL), we’ve published new information on thinking and memory changes for people with Parkinson’s.
On 12 July, 3 All-Party Parliamentary Groups met MPs to highlight the challenges people living with Parkinson’s, multiple sclerosis, Crohn’s and colitis face accessing vital disability support.
Updated trial results show NLX-112 could treat motor symptoms as well as dyskinesia. If further trials are successful, we could have a valuable new Parkinson’s drug by 2030.
The prime minister announced the NHS long-term workforce plan for England. There are some positive changes, but it's still not clear how people with Parkinson's will receive the specialist care they urgently need.
A singer-songwriter living with Parkinson's has recorded an album with all the proceeds going to Parkinson’s UK.
The last week in June is World Wellbeing Week and it's the perfect time for us all to enjoy being active.
Our Chair of Trustees has been recognised for his contributions to business and charity in the King’s birthday honours list.
Our reaction to the UK Government announcement to keep prescriptions free for 60- to 65-year-olds in England.
Results from a UK phase 2 clinical trial show that ursodeoxycholic acid (UDCA) is safe for people with Parkinson's and can increase energy production in cells in the brain.
We’re pleased to announce that our Interim Director of Community and Participation, Emma Cooper, has permanently joined our Executive Leadership Team.
To celebrate Men's Health Week, we're highlighting opportunities for people with Parkinson's to be active with the condition.
More research needed to investigate the impact of pesticides on brain cells in Parkinson’s